GenSight Biologics raises approximately EUR 500,000 through a capital increase from an existing shareholder, enhancing its operational roadmap. This comes after a prior financing of EUR 4 million announced earlier.
Amount Raised
€500,000
Round Type
Seed
ParisBiotechnologyHealth CareTherapeuticsBiopharmaInvestors
Description
GenSight Biologics has announced an additional financing of approximately EUR 500,000 from an existing shareholder. This financing allows valuable flexibility to execute its operational roadmap through October 2025. The company also discusses improvements resulting from a previous financing of EUR 4 million. This new round further supports its strategic direction and upcoming projects.
Quick answer
GenSight Biologics raised €500,000 in a Seed round, dated July 17, 2025. Investors: Existing Shareholder. GenSight Biologics is based in Paris, Ile-de-France, France.
- How much did GenSight Biologics raise?
- GenSight Biologics raised €500,000 in a Seed round on July 17, 2025.
- Who invested in GenSight Biologics?
- Existing Shareholder is named as investors in this round.
- What does GenSight Biologics do?
- GenSight Biologics is a clinical-stage biotechnology company discovering and developing novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system.
- Where is GenSight Biologics based and how big is it?
- GenSight Biologics is based in Paris, Ile-de-France, France. Fundz records about 26 employees.
- Who are the decision-makers at GenSight Biologics?
- Fundz holds 4 contacts at GenSight Biologics, including the Chief Technology Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biopharma around the same time
Companies in the same sectors as GenSight Biologics that raised within 45 days of this round, from Fundz verified event records.
- Retension Pharmaceuticals raised $15M (Series B) on August 6, 2025.
- Lysoway Therapeutics raised $2.9M (Seed) on August 6, 2025.
- DiaMedica Therapeutics raised $30M on July 23, 2025.
- DiaMedica Therapeutics raised $30M (Post-IPO Equity) on July 21, 2025.
- Os Therapies raised $4.2M on June 23, 2025.
- Ensho Therapeutics raised $23M on June 12, 2025.
Who to call at GenSight Biologics, and when
A new round usually means GenSight Biologics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day GenSight Biologics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at GenSight Biologics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at GenSight Biologics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment GenSight Biologics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
GenSight Biologics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.